The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

5.26

-0.01

(-0.19%)

At close: 04:00PM EDT

5.18

-0.08

(-1.52%)

After hours:

07:55PM EDT

Currency in USD

Earnings estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	11	11	11	10
Avg. Estimate	-0.18	-0.14	-0.64	-0.37
Low estimate	-0.32	-0.18	-0.84	-0.82
High estimate	-0.14	-0.12	-0.55	-0.11
Year ago EPS	-0.4	-0.19	-1.18	-0.64

Revenue estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	10	10	11	10
Avg. Estimate	98.05M	103.27M	399.43M	475.63M
Low estimate	96M	101.5M	390M	383M
High estimate	101.09M	105.45M	408.07M	510.06M
Year ago sales	82.49M	85.95M	331.41M	399.43M
Sales growth (year/est)	18.90%	20.20%	20.50%	19.10%

Earnings history	29/06/2023	29/09/2023	30/12/2023	30/03/2024
Est. EPS	-0.23	-0.23	-0.24	-0.21
Actual EPS	-0.4	-0.19	-0.31	-0.17
Difference	-0.17	0.04	-0.07	0.04
Surprise %	-73.90%	17.40%	-29.20%	19.00%

EPS trend	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.18	-0.14	-0.64	-0.37
7 days ago	-0.16	-0.13	-0.63	-0.35
30 days ago	-0.16	-0.13	-0.61	-0.34
60 days ago	-0.16	-0.12	-0.59	-0.3
90 days ago	-0.16	-0.15	-0.72	-0.39

EPS revisions	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	1	4	2
Up last 30 days	N/A	1	4	2
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	5	4	2	5

Growth estimates	BCRX	Industry	Sector(s)	S&P 500
Current qtr.	55.00%	N/A	N/A	N/A
Next qtr.	26.30%	N/A	N/A	N/A
Current year	45.80%	N/A	N/A	N/A
Next year	42.20%	N/A	N/A	N/A
Next 5 years (per annum)	44.80%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A